Cingulate Shares Fall to 52-Week Low After Reverse Split : v

By Josh Beckerman Shares of Cingulate, which is developing drugs using its Precision Timed Release technology, fell to a 52-week low after a 1-for-20 reverse...

Related Keywords

Josh Beckerman , Novartis , Precision Timed Release , Permanent Product Measure , Article Normal , Pharmaceuticals , Anti Depressants , Healthcare Life Sciences , Specialized Drugs Medications , Corporate Funding , Share Capital , Corporate Actions , Corporate Industrial News , Reverse Stock Splits , Stock Splits Bonus Issues , Equity Markets , Commodity Financial Market News , Content Types , Factiva Filters , C Amp Ampe Exclusion Filter , C Amp Ampe Industry News Filter , Synd , Icing , Us17248w2044 , Corporate , Industrial News , Stock Splits , Bonus Issues , Commodity , Financial Market News , Healthcare , Life Sciences , Specialized Drugs , Medications ,